Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Te...(y and the International Union of Lipopla...),Health
Navigation Links
Oregon Cosmetic Vein Center Opens in Portland, Among First on West Coast to Offer Brand New, FDA-Approved Procedures and Technologies
Date:5/28/2008
y and the International Union of Lipoplasty.
'/>"/>
| SOURCE Oregon Cosmetic Vein Center Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
2. Paramedics, EMTs in Oregon, Washington State Ratify First-Ever Teamsters Contract
3. Message to Oregon Residents: Forgo Fad Dieting and Join the Campaign for Healthy Weight
4. West Coast Bank Sponsors Reach the Bridge Run to Benefit the American Lung Association of Oregon
5. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
6. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
7. DNA Find in Oregon Is Oldest Yet Discovered in Americas
8. Oregon study raises questions on synthetic progestins
9. Providence Health & Services - Oregon Region Powers Consumer Portal With Kryptiq Connect IQ
10. Oregon researchers discover a mechanism leading to cleft palate
11. Oregon researchers find trigger gene for muscle development
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Beating Heart Differs by Gender, Age: Study 2Health News:Oxygen Therapy May Relieve Cluster Headache Pain 2Health News:Testosterone Gets Bad Rap: Study 2Health News:Testosterone Gets Bad Rap: Study 3Health News:Review Questions Tamiflu's Effectiveness 2Health News:Antares Achieves ISO Certification 2
Other Medicine News:Health News:Tanya Osborne-McKenzie Wins AMN Healthcare ACNL Scholarship 2Health News:Natural & Organic Coupon Site Offers Consumers Real-Time Savings Alerts 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 2Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 3Health News:Digital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008 4Health News:Large users of zopiclone assessed as impaired 2Health News:Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009 2Health News:Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009 3Health News:Siemens Demonstrates Flash Speed, Lowest Dose at ACC 2009 4
Tanya Osborne-McKenzie Wins AMN Healthcare ACNL ScholarshipNatural & Organic Coupon Site Offers Consumers Real-Time Savings AlertsDigital Power Reports Financial Results for the Fourth Quarter and the Year Ended December 31, 2008Large users of zopiclone assessed as impairedOn Being a Scientist: A Guide to Responsible Conduct in Research, third editionSiemens Demonstrates Flash Speed, Lowest Dose at ACC 2009
Breaking Medicine Technology:Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3Global Announces Contract To Acquire New Business 2Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 1MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 2MarketsandMarkets 3A Global Emerging Lighting Technologies Market Worth US 24112 2 Billion by 2014 55993 3Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September 13798 1Poniard Pharmaceuticals To Present at Three Upcoming Investor Conferences in September 13798 2Scientists Make Sweet Monkey Music 55988 1Scientists Make Sweet Monkey Music 55988 2
Other Medicine Technology:Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 2Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 3Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across,Multiple Migraine Attacks 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 2Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 3Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 4Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 5Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 6Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 7Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 8Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year,Alemtuzumab in Multiple Sclerosis Data Presented at AAN 9
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |